Mesenchymal Stem Cells (Medical University of South Carolina

N/A

Report date: 2023/01/12 15:29:06

Base Information

Drug NameMesenchymal Stem Cells (Medical University of South Carolina
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1Lupus Erythematosus, SystemicPancreatitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South CarolinaNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of South Carolina
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Lupus Erythematosus, SystemicPancreatitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A